IMYU Trademark

Trademark Overview

On Monday, August 14, 2023, a trademark application was filed for IMYU with the United States Patent and Trademark Office. The USPTO has given the IMYU trademark a serial number of 98131418. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, February 11, 2025. This trademark is owned by Immunovant Sciences GmbH. The IMYU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of autoimmune diseases and disorders, neuromuscular diseases and disorders, neurological diseases and disorders, and ocular diseases and disorders
imyu

General Information

Serial Number98131418
Word MarkIMYU
Filing DateMonday, August 14, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of autoimmune diseases and disorders, neuromuscular diseases and disorders, neurological diseases and disorders, and ocular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunovant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4051
CH
Party NameImmunovant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events

Event DateEvent Description
Friday, October 20, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, August 17, 2023NEW APPLICATION ENTERED
Monday, August 21, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 20, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 29, 2023ASSIGNED TO EXAMINER
Tuesday, December 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 12, 2024POST PUBLICATION AMENDMENT - ENTERED
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 10, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, February 12, 2024ASSIGNED TO PETITION STAFF
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 5, 2024SOU EXTENSION 1 FILED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 5, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 10, 2025SOU EXTENSION 1 GRANTED
Tuesday, February 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2025SOU EXTENSION 2 FILED
Wednesday, February 12, 2025SOU EXTENSION 2 GRANTED
Wednesday, February 12, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 5, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

imyu diseases disorders neuromuscular neurological ocular autoimmune preparations human prevention treatment